Arcus Biosciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Arcus Biosciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Arcus Biosciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Arcus Biosciences Inc. is RCUS:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Arcus Biosciences Inc. has its primary listing on New York Stock Exchange. You can trade Arcus Biosciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Arcus Biosciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Arcus Biosciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Arcus Biosciences Inc..